Note 19 - Commitments and Contingencies

9 Months Ended

Feb. 29, 2016

Commitments and Contingencies Disclosure [Text Block]

19.	COMMITMENTS AND CONTINGENCIES

Legal Proceedings

Immucor and BioArray Solutions Limited (“BioArray”), a wholly owned subsidiary of Immucor, are defendants in an action brought in August 2014 by Rutgers, the State University of New Jersey (“Rutgers”), in the Superior Court of New Jersey for Middlesex County, alleging breach of contract and fraud claims under a patent license between Rutgers and BioArray. The Company believes the claims are without merit and that it has meritorious defenses. The Company believes that liability is unlikely and that the amount of any liability is not currently reasonably estimable. Further, the Company believes that any potential liability would not be material to the Company’s operations or to its financial condition.

From time to time the Company is a party to certain legal proceedings in the ordinary course of business. However, the Company is not currently subject to any legal proceedings expected to have a material adverse effect on its consolidated financial position, result of operations or cash flow.

Purchase Commitments

Purchase commitments made in the normal course of business were $48.0 million as of February 29, 2016. These purchases were primarily for inventory items. The following is a schedule of the approximate future payments for purchase commitments as of February 29, 2016 (in thousands):

Year ended May 31:
2016	$	10,720
2017		21,660
2018		4,405
2019		4,344
2020		4,291
Thereafter		2,567
	$	47,987